Tender detail

Non-exclusive rebate agreement for filgrastim for 2027, with a 12-month extension option

Summary

DAK-Gesundheit and the participating statutory health insurers are seeking non-exclusive pharmaceutical rebate agreements with interested pharmaceutical companies for medicines containing filgrastim (ATC L03AA02). The agreements are scheduled to run from 1 January to 31 December 2027, with an option to extend once for 12 months; they end earlier if an exclusive agreement for the active substance takes effect.

Reference number
541d6f20-e212-48d4-a8b6-ceeae60b5669
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-11-19
Status
Open
Contract subject
Supplies
Estimated value
1,00 EUR
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.